Haoxi Health Seeks Shareholder Approval for Massive Capital Increase and Extreme Reverse Stock Split Authority
HAO sits 17% above its 52-week low of $1.39.
Summary
Haoxi Health Technology is asking shareholders to approve an astronomical increase in authorized shares and authorization for an extreme reverse stock split, signaling severe financial distress and potential for massive dilution.
Key Events · Financing and Capital Events · HAO
-
Massive Authorized Share Capital Increase Proposed
Shareholders will vote on increasing authorized share capital from approximately 9.38 million shares to over 859 billion shares (post-split equivalent), creating an immense potential for future dilution.
-
Extreme Reverse Stock Split Authority Sought
The company is seeking authorization for the Board to implement one or more reverse stock splits at an aggregate cumulative ratio of up to 1-for-8,000, aimed at regaining Nasdaq listing compliance. This follows a 1:128 reverse split executed today.
-
Amendments to Memorandum and Articles of Association
Proposals include adopting new M&AA to reflect the share capital increase and reverse split, and a change in quorum requirements for shareholder meetings.
-
Meeting Scheduled for June 2, 2026
An Extraordinary General Meeting is scheduled for June 2, 2026, for shareholders to vote on these critical proposals.
Analysis · HAO · Trade & Services
Haoxi Health Technology is seeking shareholder approval for a colossal increase in its authorized share capital, from approximately 9.38 million shares to over 859 billion shares (post-split equivalent). This authorization, if fully utilized, represents an extreme potential for dilution that could severely impact existing shareholder value. Concurrently, the company is requesting authority for the Board to implement further reverse stock splits at an aggregate cumulative ratio of up to 1-for-8,000, explicitly to maintain compliance with Nasdaq's minimum bid price rules. This comes on the same day a 1:128 reverse split was executed, indicating severe and ongoing stock price distress and a desperate attempt to avoid delisting. The combination of these proposals signals a company in profound financial difficulty, preparing for significant capital raises that could drastically dilute current ownership.
At the time of this filing, HAO was trading at $1.63 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $107.3M. The 52-week trading range was $1.39 to $295.68. This filing was assessed with negative market sentiment and an importance score of 10 out of 10.